Eli Lilly | Des Atouts


Assets Changement
ALKERMES ALKS:US $ 1957.42M 20.43M
Amgen AMGN:US $ 59294M 98M
AstraZeneca AZN:LN 96579M 3694M
Astrazeneca AZN:US $ 96579M 3694M
Baxter International BAX:US $ 31831M 885M
Biogen BIIB:US $ 25081.4M 1467M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Catalent CTLT:US $ 10322M 119M
Coherus Biosciences CHRS:US $ 546M 47.38M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Endo International Ordinary Shares ENDP:US $ 6362.26M 2084.95M
Gilead Sciences GILD:US $ 62870M 210M
GlaxoSmithKline GSK:LN 89045M 644M
Glaxosmithkline GSK:US $ 89045M 644M
Horizon Pharma HZNP:US $ 8853.47M 113.14M
Intercept Pharmaceuticals ICPT:US $ 498.6M 4.76M
JAZZ PHA JAZZ:US $ 11200.13M 568.78M
Lannett LCI:US $ 572.31M 22.63M
Medtronic MDT:US $ 90981M 823M
Neurocrine Biosciences NBIX:US $ 2005.7M 138.8M
Novartis NOVN:VX SF 122910M 2308M
Novartis NVS:US $ 122910M 2308M
Perrigo Ordinary Shares PRGO:US $ 10919.6M 530.1M
Phibro Animal Health PAHC:US $ 916.18M 67.22M
Prestige Brands PBH:US $ 3682.23M 11.55M
Regeneron Pharmaceuticals REGN:US $ 27205.8M 857.1M
Revance Therapeutics RVNC:US $ 561.88M 77.66M
Teva Pharmaceutical Industries TEVA:US $ 45932M 1127M
United Therapeutics UTHR:US $ 5543.3M 183.5M
Zoetis ZTS:US $ 13770M 90M



Eli Lilly Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2022.